Advertisement
Loading...

Cingulate Inc.

CINGNASDAQ
Healthcare
Biotechnology
$4.39
$-0.09(-2.01%)
U.S. Market opens in 5h 13m

Cingulate Inc. (CING) Stock Overview

Explore Cingulate Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap24.6M
P/E Ratio-1.54
EPS (TTM)$-4.33
ROE-3.68%
Fundamental Analysis

AI Price Forecasts

1 Month$6.42
3 Months$5.70
1 Year Target$17.31

CING Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cingulate Inc. (CING) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $17.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.54 and a market capitalization of 24.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.01%
5-Day Change
-6.79%
1-Month Change
-19.45%
3-Month Change
-27.44%
6-Month Change
28.36%
Year-to-Date (YTD) Change
1.15%
1-Year Change
15.22%
3-Year Change
-98.13%
5-Year Change
-99.59%
All-Time (Max) Change
-99.59%

Contact Information

913 942 2300
1901 West 47th Place, Kansas City, KS, 66205

Company Facts

13 Employees
IPO DateDec 8, 2021
CountryUS
Actively Trading

Frequently Asked Questions